| Over the past | Total investment | Would've become | Historic returns | Returns |
|---|---|---|---|---|
| 6 months | ₹30,000 | ₹29,422 | -1.93% | |
| 1 year | ₹60,000 | ₹61,770 | +2.95% | |
| 3 years | ₹1,80,000 | ₹2,04,988 | +13.88% | |
| 5 years | ₹3,00,000 | ₹4,17,935 | +39.31% |
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 9.59% |
| Divi's Laboratories Ltd | Healthcare | Equity | 9.07% |
| Neuland Laboratories Ltd | Healthcare | Equity | 6.14% |
| Torrent Pharmaceuticals Ltd | Healthcare | Equity | 6.04% |
| Apollo Hospitals Enterprise Ltd | Healthcare | Equity | 5.75% |
| Aurobindo Pharma Ltd | Healthcare | Equity | 5.23% |
| Navin Fluorine International Ltd | Materials | Equity | 4.98% |
| Zydus Lifesciences Ltd | Healthcare | Equity | 4.97% |
| Aster DM Healthcare Ltd | Healthcare | Equity | 4.61% |
| Fortis Healthcare Ltd | Healthcare | Equity | 3.77% |
| Metropolis Healthcare Ltd | Healthcare | Equity | 3.35% |
| Gland Pharma Ltd | Healthcare | Equity | 3.20% |
| Mankind Pharma Ltd. | Healthcare | Equity | 3.11% |
| Nephrocare Health Services Ltd. | Healthcare | Equity | 3.05% |
| Max Healthcare Institute Ltd | Healthcare | Equity | 2.99% |
| Suven Pharmaceuticals Ltd | Healthcare | Equity | 2.95% |
| Glenmark Pharmaceuticals Ltd | Healthcare | Equity | 2.61% |
| Global Health Ltd | Healthcare | Equity | 2.59% |
| Repo | Unspecified | Repo | 2.57% |
| Dr. Agarwal’S Health Care Ltd. | Healthcare | Equity | 2.46% |
| Biocon Ltd | Healthcare | Equity | 2.37% |
| Ipca Laboratories Ltd | Healthcare | Equity | 2.33% |
| Onesource Specialty Pharma Ltd | Healthcare | Equity | 2.30% |
| Piramal Pharma Ltd | Healthcare | Equity | 1.43% |
| Syngene International Ltd | Healthcare | Equity | 1.38% |
| Artemis Medicare Services Ltd | Healthcare | Equity | 1.26% |
| Net Payables | Unspecified | Net Payables | -0.10% |
| Name | 1Y | 3Y | 5Y | All |
|---|---|---|---|---|
| Fund returns | +3.4% | +18.2% | +10.5% | +16.0% |
| Category average (Equity Sectoral) | +6.9% | +18.3% | +12.7% | +16.8% |
| Rank (Equity Sectoral) | 21 | 9 | 11 | -- |